Design of pharmacokinetic studies for latent covariates

Journal of Pharmacokinetics and Pharmacodynamics

Volumn 39, Issue 1, 2012, Pages 87-97

  Lagishetty, Chakradhar V ^a   Coulter, Carolyn V ^a   Duffull, Stephen B ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Design studies; Latent covariate; Linear regression; Non linear mixed effects modelling, simulation and power analysis

Indexed keywords

ALGORITHM; ALLELE; ARTICLE; COMPUTER SIMULATION; CONTROLLED STUDY; COPY NUMBER VARIATION; COVARIANCE; DRUG CLEARANCE; HAPLOTYPE; LINEAR SYSTEM; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; NONLINEAR SYSTEM; PHARMACOLOGICAL SCIENCE; PHENOTYPIC VARIATION; POWER ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROCESS DESIGN; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE FACTORS; ALGORITHMS; BIAS (EPIDEMIOLOGY); COMPUTER SIMULATION; EPIDEMIOLOGIC RESEARCH DESIGN; HUMANS; LINEAR MODELS; METABOLIC CLEARANCE RATE; MODELS, STATISTICAL; NONLINEAR DYNAMICS; PHARMACOKINETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA; SAMPLE SIZE; TELOMERASE;

EID: 84861480571     PISSN: 1567567X     EISSN: 15738744     Source Type: Journal    
DOI: 10.1007/s10928-011-9231-3     Document Type: Article

References (21)

1. Bonate PL (2005) Pharmacokinetic-pharmacodynamic modelling and simulation. Springer, New York
2. Ribbing J, Jonsson EN (2004) Power, selection bias and predictive performance of the Population Pharmacokinetic Covariate Model. J Pharmacokinet Pharmacodyn 31:109-134 (Pubitemid 38932393)
3. Miller AJ (1984) Selection of subsets of regression variables. J R Stat Soc 147:389-425
4. Bonate PL (1999) The effect of collinearity on parameter estimates in nonlinear mixed effect models. Pharm Res 16:709-717
5. Silva R, Scheines C, Glymour C, Spirtes P (2006) Learning the structure of linear latent variable models. J Mach Learn Res 7:191-246 (Pubitemid 43668126)
6. Silva R, Scheines R, Glymour C, Spirtes P (2003) Learning measurement models for unobserved variables. In: Kjaerulff U, Meek C (eds) Proceedings of the nineteenth conference on uncertainty in artificial intelligence. Morgan Kauffman, Acapulco
7. Bertrand J, Comets E, Mentre F (2008) Comparison of model-based tests and selection strategies to detect genetic polymorphisms influencing pharmacokinetic parameters. Biopharm Stat 18:1084-1102
8. Bertrand J, Comets E, Laffont CM, Chenel M, Mentre F (2009) Pharmacogenetics and population pharmacokinetics: impact of the design on three tests using the SAEM algorithm. J Pharmacokinet Pharmacodyn 36:317-339
9. Codd V et al (2010) Common variants near TERC are associated with mean telomere length. Nat Genet 42:197-199
10. Foo LK, Duffull SD (2011) Optimal design of pharmacokinetic- pharmacodynamic studies. In: Bonate P (ed) Pharmacokinetics in drug development, advances and applications, vol 3. Springer, New York
11. Han PY, Kirkpatrick CM, Green B (2009) Informative study designs to identify true parameter-covariate relationships. J Pharmacokinet Pharmacodyn 36:147-163
12. Beal SL (1994) NONMEM users guides. University of California at San Francisco, San Francisco
13. Senn S (2003) Disappointing dichotomies. Pharm Stat 2:239-240
14. Kowalski G, Hutmacher HM (2001) Design evaluation for a population pharmacokinetic study using clinical trial simulations: a case study. Stat Med 20:75-91
15. Lee PI (2001) Design and power of a population pharmacokinetic study. Pharm Res 18:75-82
16. Nakade S, Nishibori A, Okamoto H, Higuchi S (2004) Statistical evaluation of clinical trial design for a population pharmacokinetic study - a case study. Drug Metab Pharmacokinet 19:381-389
17. Bonate PL (2005) Covariate detection in population pharmacokinetics using partially linear mixed effects models. Pharm Res 22:541-549
18. Wahlby U, Bouw MR, Jonsson EN, Karlsson MO (2002) Assessment of type I error rates for the statistical sub-model in NONMEM. J Pharmacokinet Pharmacodyn 29:251-269 (Pubitemid 35333142)
19. Wahlby U, Jonsson EN, Karlsson MO (2001) Assessment of actual significance levels for covariate effects in NONMEM. J Pharmacokinet Pharmacodyn 28:231-252 (Pubitemid 32643366)
20. Wahlby U, Matolcsi K, Karlsson MO, Jonsson EN (2004) Evaluation of type I error rates when modeling ordered categorical data in NONMEM. J Pharmacokinet Pharmacodyn 31:61-74 (Pubitemid 38870190)
21. Holford N, Kirkpatrick C, Duffull S (2006) NONMEM termination status is not an important indicator of the quality of bootstrap parameter estimates, p 15, Abstr 992 [http://www.pagemeetingorg/?abstract=992], Brugge/Bruges, Belgium. Accessed Oct 2011